These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8360875)

  • 1. Synthesis and evaluation of conformationally restricted N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamines at sigma receptors. 2. Piperazines, bicyclic amines, bridged bicyclic amines, and miscellaneous compounds.
    de Costa BR; He XS; Linders JT; Dominguez C; Gu ZQ; Williams W; Bowen WD
    J Med Chem; 1993 Aug; 36(16):2311-20. PubMed ID: 8360875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of conformationally restricted 2-(1-pyrrolidinyl)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methylethylenediam ines as sigma receptor ligands. 1. Pyrrolidine, piperidine, homopiperidine, and tetrahydroisoquinoline classes.
    de Costa BR; Dominguez C; He XS; Williams W; Radesca L; Bowen W
    J Med Chem; 1992 Nov; 35(23):4334-43. PubMed ID: 1447735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and receptor binding properties of fluoro- and iodo-substituted high affinity sigma receptor ligands: identification of potential PET and SPECT sigma receptor imaging agents.
    de Costa B; Radesca L; Dominguez C; Di Paolo L; Bowen WD
    J Med Chem; 1992 Jun; 35(12):2221-30. PubMed ID: 1319493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new approach to the design of sigma-2-selective ligands: synthesis and evaluation of N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)ethylamine-related polyamines at sigma-1 and sigma-2 receptor subtypes.
    de Costa BR; He XS; Dominguez C; Cutts J; Williams W; Bowen WD
    J Med Chem; 1994 Jan; 37(2):314-21. PubMed ID: 8295220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of aryl-substituted N-(arylethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamines and corresponding arylacetamides for sigma receptor affinity.
    Zhang Y; Williams W; Bowen WD; Rice KC
    J Med Chem; 1996 Aug; 39(18):3564-8. PubMed ID: 8784455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines: structural requirements and binding affinity at the sigma receptor.
    de Costa BR; Radesca L; Di Paolo L; Bowen WD
    J Med Chem; 1992 Jan; 35(1):38-47. PubMed ID: 1310114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and binding characteristics of potential SPECT imaging agents for sigma-1 and sigma-2 binding sites.
    He XS; Bowen WD; Lee KS; Williams W; Weinberger DR; de Costa BR
    J Med Chem; 1993 Mar; 36(5):566-71. PubMed ID: 8496936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of N-substituted cis-N-methyl-2-(1-pyrrolidinyl)cyclohexylamines as high affinity sigma receptor ligands. Identification of a new class of highly potent and selective sigma receptor probes.
    de Costa BR; Rice KC; Bowen WD; Thurkauf A; Rothman RB; Band L; Jacobson AE; Radesca L; Contreras PC; Gray NM
    J Med Chem; 1990 Nov; 33(11):3100-10. PubMed ID: 2172538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting sigma1 receptors produce anti-cocaine effects in mice.
    Matsumoto RR; McCracken KA; Friedman MJ; Pouw B; De Costa BR; Bowen WD
    Eur J Pharmacol; 2001 May; 419(2-3):163-74. PubMed ID: 11426838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice.
    Matsumoto RR; McCracken KA; Pouw B; Miller J; Bowen WD; Williams W; De Costa BR
    Eur J Pharmacol; 2001 Jan; 411(3):261-73. PubMed ID: 11164383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, configuration, and activity of isomeric 2-phenyl-2-(N-piperidinyl)bicyclo[3.1.0]hexanes at phencyclidine and sigma binding sites.
    de Costa BR; Mattson MV; George C; Linders JT
    J Med Chem; 1992 Dec; 35(25):4704-12. PubMed ID: 1469699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vitro validation and in vivo pharmacokinetics of [125I]N-[2-(4-iodophenyl)ethyl]-N-methyl-2-(1-piperidinyl) ethylamine: a high-affinity ligand for imaging sigma receptor positive tumors.
    John CS; Gulden ME; Vilner BJ; Bowen WD
    Nucl Med Biol; 1996 Aug; 23(6):761-6. PubMed ID: 8940718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel sigma receptor ligands attenuate the locomotor stimulatory effects of cocaine.
    McCracken KA; Bowen WD; Matsumoto RR
    Eur J Pharmacol; 1999 Jan; 365(1):35-8. PubMed ID: 9988120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
    Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
    Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformationally constrained ethylenediamines: synthesis and receptor binding of 6,8-diazabicyclo[3.2.2]nonanes.
    Weigl M; Bedürftig S; Maier CA; Wünsch B
    Bioorg Med Chem; 2002 Jul; 10(7):2245-57. PubMed ID: 11983522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
    Monnet FP; de Costa BR; Bowen WD
    Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
    Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
    J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substituted halogenated arylsulfonamides: a new class of sigma receptor binding tumor imaging agents.
    John CS; Lim BB; Vilner BJ; Geyer BC; Bowen WD
    J Med Chem; 1998 Jul; 41(14):2445-50. PubMed ID: 9651150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes.
    Nguyen VH; Kassiou M; Johnston GA; Christie MJ
    Eur J Pharmacol; 1996 Sep; 311(2-3):233-40. PubMed ID: 8891604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.
    Bonhaus DW; Loury DN; Jakeman LB; To Z; DeSouza A; Eglen RM; Wong EH
    J Pharmacol Exp Ther; 1993 Nov; 267(2):961-70. PubMed ID: 8246171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.